.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Chinese Patent Office
QuintilesIMS
Moodys
Covington
Cantor Fitzgerald
Express Scripts
Fuji
Johnson and Johnson

Generated: December 16, 2017

DrugPatentWatch Database Preview

WELLCOVORIN Drug Profile

« Back to Dashboard

When do Wellcovorin patents expire, and when can generic versions of Wellcovorin launch?

Wellcovorin is a drug marketed by Glaxosmithkline and is included in five NDAs.

The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Drug patent expirations by year for WELLCOVORIN

Medical Subject Heading (MeSH) Categories for WELLCOVORIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
GlaxosmithklineWELLCOVORINleucovorin calciumINJECTABLE;INJECTION087439-001Oct 19, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineWELLCOVORINleucovorin calciumINJECTABLE;INJECTION089834-001Jan 23, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineWELLCOVORINleucovorin calciumINJECTABLE;INJECTION089833-001Jan 23, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineWELLCOVORINleucovorin calciumINJECTABLE;INJECTION089465-001Jan 23, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineWELLCOVORINleucovorin calciumTABLET;ORAL018342-002Jul 8, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineWELLCOVORINleucovorin calciumTABLET;ORAL018342-001Jul 8, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Healthtrust
Novartis
Fish and Richardson
Merck
Johnson and Johnson
Cipla
Medtronic
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot